Carl Zeiss Meditec AG is one of the world’s leading medical technology companies. The company offers complete solutions to diagnose and treat ophthalmic diseases. In the field of microsurgery the company provides innovative visualization solutions.
ZEISS´ medical technology portfolio is rounded off by promising future-oriented technologies such as intraoperative radiotherapy.
|Owners:||The Carl Zeiss Meditec AG is listed on the TecDAX of the German stock exchange (ISIN DE 0005313704); 65 percent of the shares are held by Carl Zeiss AG. The remaining shares are in free float.|
|Locations:||Besides its headquarters in Jena/ Germany, ZEISS has subsidiaries in the USA, Japan, Germany, Spain and France. Additional Research and Development Centers in India and China strengthen the company's presence in these rapidly developing economies. In other countries the company makes use of the vast distribution network of Carl Zeiss AG.|
|Revenue:||€906.4 million (FY 2012/2013)*|
|Board:||• Dr. Ludwin Monz (President and CEO)
• Dr. Christian Müller, Thomas Simmerer
|Employees:||The Carl Zeiss Meditec AG has around 2,500 employees worldwide, including around 400 at the headquarters in Jena (as of September 30, 2012).*|
* Revenue and number of employees deviate from the published figures of the Medical Technology business group of Carl Zeiss AG as a result of different consolidation models.
Su questo sito Web utilizziamo cookie. I cookie sono piccoli file di testo che vengono memorizzati dai siti Web sul computer dell’utente. Ampiamente utilizzati, i cookie sono strumenti di ausilio per migliorare le pagine e rappresentarle in maniera ottimizzata. Consultando le nostre pagine l’utente acconsente al loro impiego. Di più